Hudig D[au] - Search Results

Year	Number of Results
1978	1
1979	3
1980	1
1981	4
1982	1
1983	2
1984	4
1985	2
1987	1
1988	3
1989	1
1990	1
1991	1
1992	2
1993	5
1994	3
1996	4
1997	4
1998	5
2000	2
2001	1
2002	1
2003	1
2004	1
2005	2
2006	1
2008	2
2009	4
2013	2
2014	2
2017	1
2018	1
2020	3
2022	1

1

Proteases and lymphocyte cytotoxic killing mechanisms.

Hudig D, Ewoldt GR, Woodard SL. Hudig D, et al. Curr Opin Immunol. 1993 Feb;5(1):90-6. doi: 10.1016/0952-7915(93)90086-8. Curr Opin Immunol. 1993. PMID: 8452680 Review.

2

Lysis by RNK-16 cytotoxic lymphocyte granules. Rate assays and conditions to study control of cytolysis.

Hudig D, Callewaert DM, Redelman D, Allison NJ, Krump M, Tardieu B. Hudig D, et al. J Immunol Methods. 1988 Dec 9;115(2):169-77. doi: 10.1016/0022-1759(88)90285-2. J Immunol Methods. 1988. PMID: 3198921

3

Antibody-Dependent Cell-mediated Cytotoxicity (ADCC) in Familial Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Sung AP, Tang JJ, Guglielmo MJ, Smith-Gagen J, Bateman L, Navarrete-Galvan L, Redelman DD, Hudig D. Sung AP, et al. Among authors: hudig d. Fatigue. 2020;8(4):226-244. doi: 10.1080/21641846.2021.1876613. Epub 2021 Feb 2. Fatigue. 2020. PMID: 33777500 Free PMC article.

4

Natural Killer (NK) Cell Expression of CD2 as a Predictor of Serial Antibody-Dependent Cell-Mediated Cytotoxicity (ADCC).

Tang JJ, Sung AP, Guglielmo MJ, Navarrete-Galvan L, Redelman D, Smith-Gagen J, Hudig D. Tang JJ, et al. Among authors: hudig d. Antibodies (Basel). 2020 Oct 16;9(4):54. doi: 10.3390/antib9040054. Antibodies (Basel). 2020. PMID: 33081115 Free PMC article.

5

Inclusion of family members without ME/CFS in research studies promotes discovery of biomarkers specific for ME/CFS.

Tokunaga K, Sung AP, Tang JJ, Guglielmo MJ, Smith-Gagen J, Bateman L, Redelman DD, Hudig D. Tokunaga K, et al. Among authors: hudig d. Work. 2020;66(2):327-337. doi: 10.3233/WOR-203177. Work. 2020. PMID: 32568152

6

Granzymes (lymphocyte serine proteases): characterization with natural and synthetic substrates and inhibitors.

Kam CM, Hudig D, Powers JC. Kam CM, et al. Among authors: hudig d. Biochim Biophys Acta. 2000 Mar 7;1477(1-2):307-23. doi: 10.1016/s0167-4838(99)00282-4. Biochim Biophys Acta. 2000. PMID: 10708866 Review.

7

Optimizing NK-92 serial killers: gamma irradiation, CD95/Fas-ligation, and NK or LAK attack limit cytotoxic efficacy.

Navarrete-Galvan L, Guglielmo M, Cruz Amaya J, Smith-Gagen J, Lombardi VC, Merica R, Hudig D. Navarrete-Galvan L, et al. Among authors: hudig d. J Transl Med. 2022 Apr 2;20(1):151. doi: 10.1186/s12967-022-03350-6. J Transl Med. 2022. PMID: 35366943 Free PMC article.

8

An improved method to quantify human NK cell-mediated antibody-dependent cell-mediated cytotoxicity (ADCC) per IgG FcR-positive NK cell without purification of NK cells.

Sung AP, Tang JJ, Guglielmo MJ, Redelman D, Smith-Gagen J, Bateman L, Hudig D. Sung AP, et al. Among authors: hudig d. J Immunol Methods. 2018 Jan;452:63-72. doi: 10.1016/j.jim.2017.11.002. Epub 2017 Nov 4. J Immunol Methods. 2018. PMID: 29113954

9

Hydrolysis of tumor cell lipids after CTL-mediated death.

Alves B, Leong J, Tamang DL, Elliott V, Lowe M, Hudig D. Alves B, et al. Among authors: hudig d. Int Immunol. 2009 May;21(5):543-53. doi: 10.1093/intimm/dxp026. Epub 2009 Mar 26. Int Immunol. 2009. PMID: 19325035 Free PMC article.

10

Regulation of perforin lysis: implications for protein disulfide isomerase proteins.

Tamang DL, Alves BN, Elliott V, Redelman D, Wadhwa R, Fraser SA, Hudig D. Tamang DL, et al. Among authors: hudig d. Cell Immunol. 2009;255(1-2):82-92. doi: 10.1016/j.cellimm.2008.12.001. Epub 2009 Jan 14. Cell Immunol. 2009. PMID: 19147124 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results